Opioid Use After Urogynecologic Procedures: Using a Predictive Calculator

Sponsor
David Sheyn (Other)
Overall Status
Recruiting
CT.gov ID
NCT05571072
Collaborator
(none)
118
1
2
22
5.4

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if the investigators can precisely predict how much pain medication the subjects will need after surgery using a special calculator that was developed for this purpose.

Condition or Disease Intervention/Treatment Phase
  • Other: Opioid calculator
  • Other: Standard opioid prescription
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Opioid Use After Urogynecologic Procedures: Using a Predictive Calculator
Actual Study Start Date :
Jan 2, 2023
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Opioid Prescription

Patients will be given a prescription for opioid pain medication to use for acute postoperative pain as would be typical for the attending surgeon performing the surgery.

Other: Standard opioid prescription
Patients will receive prescription for post-operative opioids based on what the attending surgeon usually provides.

Experimental: Opioid Calculator Prescription

Patients will be a given a prescription for opioid pain medication based on the opioid calculator.

Other: Opioid calculator
Our research group previously created an Opioid calculator that can be used to predict the number of opioids needed post-operatively based on patient health history and characteristics.

Outcome Measures

Primary Outcome Measures

  1. Change in pain scores measured by team-created pain questionnaires [baseline, 1 week post-op, 2 weeks post-op]

    Pain questionnaire is a 2 question survey that ask patients to rate pain on scale of 0 (no pain) to 10 (worst pain) immediately post-op and current. Baseline will be calculated by asking patient's expected post-op pain score.

Secondary Outcome Measures

  1. Change in satisfaction scores measured by team-created questionnaire [1 week post-op, 2 weeks post-op]

    Questionnaire is a 1 question survey that ask patients to rate their satisfaction with their pain control on scale of 0 (totally unsatisfied) to 10 (totally satisfied) immediately post-op and current.

  2. Change in number of opioid tablets remaining measured by team-created questionnaire [1 week post-op, 2 weeks post-op]

    Patients will be asked the number of tablets remaining from their opioid prescriptions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-89

  • Able to provide informed consent

  • Patients undergoing any of below urogynecologic procedures

Included urogynecologic procedures:
  1. Sacrocolpopexy - robotic or laparoscopic

  2. With or without hysterectomy

  3. With or without salpingo-oophorectomy

  4. With or without anterior colporrhaphy

  5. With or without posterior colporrhaphy/perineorrhaphy

  6. With or without midurethral sling

  7. Sacrospinous ligament fixation

  8. With or without hysterectomy

  9. With or without salpingo-oophorectomy

  10. With or without anterior colporrhaphy

  11. With or without posterior colporrhaphy/perineorrhaphy

  12. With or without midurethral sling

  13. Uterosacral ligament suspension - robotic, laparoscopic, or vaginal

  14. With or without hysterectomy

  15. With or without salpingo-oophorectomy

  16. With or without anterior colporrhaphy

  17. With or without posterior colporrhaphy/perineorrhaphy

  18. With or without midurethral sling

  19. Colpocleisis

  20. Lefort colpocleisis

  21. Complete colpectomy with colpocleisis

  22. Isolated anterior and/or posterior colporrhaphy

Exclusion Criteria:
  • Non-English speakers

  • pre-operative diagnosis of cancer

  • scheduled for any concurrent non-urogynecologic procedure (ex: abdominoplasty)

  • <18 years or >89 years of age

  • unable to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospitals Cleveland Medical Center Cleveland Ohio United States 44106

Sponsors and Collaborators

  • David Sheyn

Investigators

  • Principal Investigator: David Sheyn, MD, University Hospitals Cleveland Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David Sheyn, Associate Professor of Urology, University Hospitals Cleveland Medical Center
ClinicalTrials.gov Identifier:
NCT05571072
Other Study ID Numbers:
  • STUDY20221287
First Posted:
Oct 7, 2022
Last Update Posted:
Jan 18, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by David Sheyn, Associate Professor of Urology, University Hospitals Cleveland Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2023